These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 1087180

  • 21. Reversal of the in vitro methotrexate suppression of cell-mediated immune response by folinic acid and thymidine plus hypoxanthine.
    Bogyo D, Mihich E.
    Cancer Res; 1980 Mar; 40(3):650-4. PubMed ID: 6970615
    [Abstract] [Full Text] [Related]

  • 22. Critical modulation by thymidine and hypoxanthine of sequential methotrexate-5-fluorouracil synergism in murine L1210 cells.
    Piper AA, Nott SE, Mackinnon WB, Tattersall MH.
    Cancer Res; 1983 Nov; 43(11):5101-5. PubMed ID: 6616448
    [Abstract] [Full Text] [Related]

  • 23. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
    Joannon P, Oviedo I, Campbell M, Tordecilla J.
    Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
    [Abstract] [Full Text] [Related]

  • 24. Biochemical factors in the selectivity of leucovorin rescue: selective inhibition of leucovorin reactivation of dihydrofolate reductase and leucovorin utilization in purine and pyrimidine biosynthesis by methotrexate and dihydrofolate polyglutamates.
    Goldman ID, Matherly LH.
    NCI Monogr; 1987 Jul; (5):17-26. PubMed ID: 2448654
    [Abstract] [Full Text] [Related]

  • 25. Toxicity of trimetrexate on hemopoietic progenitor cells in normal mice.
    Bogliolo GV, Lerza RA, Mencoboni MP, Saviane AG, Pannacciulli IM.
    Anticancer Res; 1988 Jul; 8(2):229-31. PubMed ID: 2966606
    [Abstract] [Full Text] [Related]

  • 26. Leucovorin antagonizes the effects of trimetrexate on mouse hemopoietic progenitors.
    Lerza R, Mencoboni M, Bogliolo G, Flego G, Gasparini L, Pannacciulli I.
    Anticancer Res; 1991 Jul; 11(2):613-6. PubMed ID: 1829599
    [Abstract] [Full Text] [Related]

  • 27. Leucovorin and maximum tolerated dose toxicity of methotrexate in rats.
    Fuskevåg OM, Kristiansen C, Lindal S, Aarbakke J.
    Pediatr Hematol Oncol; 2000 Dec; 17(8):651-8. PubMed ID: 11127396
    [Abstract] [Full Text] [Related]

  • 28. Interference with nucleoside transport in mouse lymphoma cells proliferating in culture.
    Warnick CT, Muzik H, Paterson AR.
    Cancer Res; 1972 Oct; 32(10):2017-22. PubMed ID: 4673140
    [No Abstract] [Full Text] [Related]

  • 29. Activity of acetyl-n-ser-asp-lys-pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow cultures.
    Jackson JD, Yan Y, Ewel C, Talmadge JE.
    Exp Hematol; 1996 Feb; 24(3):475-81. PubMed ID: 8599978
    [Abstract] [Full Text] [Related]

  • 30. Amelioration by leucovorin of methotrexate developmental toxicity in rabbits.
    DeSesso JM, Goeringer GC.
    Teratology; 1991 Mar; 43(3):201-15. PubMed ID: 2014483
    [Abstract] [Full Text] [Related]

  • 31. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
    Sirotnak FM, Otter GM, Schmid FA.
    Cancer Res; 1993 Feb 01; 53(3):587-91. PubMed ID: 8425192
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [In vitro cytotoxicity of methotrexate].
    Maehara S.
    Nihon Seikeigeka Gakkai Zasshi; 1984 Jul 01; 58(7):677-84. PubMed ID: 6334123
    [Abstract] [Full Text] [Related]

  • 35. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.
    Wosikowski K, Biedermann E, Rattel B, Breiter N, Jank P, Löser R, Jansen G, Peters GJ.
    Clin Cancer Res; 2003 May 01; 9(5):1917-26. PubMed ID: 12738750
    [Abstract] [Full Text] [Related]

  • 36. Biochemical and cell cycle perturbations in methotrexate-treated cells.
    Taylor IW, Slowiaczek P, Francis PR, Tattersall MH.
    Mol Pharmacol; 1982 Jan 01; 21(1):204-10. PubMed ID: 6982394
    [Abstract] [Full Text] [Related]

  • 37. Relative biochemical aspects of low and high doses of methotrexate in mice.
    Zaharko DS, Fung WP, Yang KH.
    Cancer Res; 1977 Jun 01; 37(6):1602-7. PubMed ID: 870175
    [Abstract] [Full Text] [Related]

  • 38. Purine modulation of methotrexate cytotoxicity in mammalian cell lines.
    Taylor IW, Slowiaczek P, Francis PR, Tattersall MH.
    Cancer Res; 1982 Dec 01; 42(12):5159-64. PubMed ID: 6958362
    [Abstract] [Full Text] [Related]

  • 39. Leucovorin rescue of human cancer and bone marrow cells following edatrexate or methotrexate.
    Jolivet J, Jansen G, Peters GJ, Pinard MF, Schornagel JH.
    Biochem Pharmacol; 1994 Feb 11; 47(4):659-65. PubMed ID: 7510479
    [Abstract] [Full Text] [Related]

  • 40. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
    Bilgeri R, Petzer AL, Zilian U, Geisen FH, Schirmer M, Haun M, Konwalinka G.
    Exp Hematol; 1993 Mar 11; 21(3):432-7. PubMed ID: 8095026
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.